Managing GIST resistance to standard TKI therapy

Date 09 September 2017
Event ESMO 2017 Congress
Session State of the science of targeted treatment in sarcoma
Topics Anti-Cancer Agents & Biologic Therapy
GIST
Personalised Medicine
Sarcoma
Presenter Heikki Joensuu
Authors H. Joensuu
  • -, Helsinki University Central Hospital, 00029 - Helsinki/FI